Currently Viewing:
Managed Care Cast

What Is and Is Not in Trump's Drug Pricing Plan: An Interview With Dr Michael Chernew

American Patients First, President Donald Trump's blueprint to bring down the cost of drug pricing is the result of a campaign promise to drive down out-of-pocket costs for consumers. Those who helped craft the proposal say it represents real reform. However, critics say it goes too easy on the pharmaceutical industry.
American Patients First, President Donald Trump's blueprint to bring down the cost of drug pricing is the result of a campaign promise to drive down out-of-pocket costs for consumers. Those who helped craft the proposal say it represents real reform. However, critics say it goes too easy on the pharmaceutical industry.

Mary Caffrey, the managing editor of The American Journal of Managed Care® (AJMC®)s Evidence-Based series, spoke with Harvard healthcare economist Michael E. Chernew, PhD, who is the co-editor in chief of AJMC®, to discuss elements of the Trump administration proposal to control drug prices. Chernew is also a former vice chair of the Medicare Payment Advisory Commission.

To listen, login to the website.



Listen above or through one of these podcast services:

Read more:

Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen"

Azar Stumps for Plan to Hold Down Prescription Drug Costs

Trump Targets Drug Prices, Right-to-Try in State of the Union

Will Trump Take Steps to Rein in Drug Prices?

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up